Table 4 Prevalence of fluoroquinolone resistance genes among various CoNS species and various clinical samples
Source | CoNS (n = 91) | |||||||
|---|---|---|---|---|---|---|---|---|
Catheter n (%) | Wound n (%) | Urine n (%) | Blood n (%) | Resistance genes | S. epidermidis (n = 5) | S. haemolyticus (n = 4) | S. saprophyticus (n = 2) | Total n (%) |
2 (100) | 0 (0) | 2 (100) | 4 (57.1) | gyrA | 4 (80) | 2 (50) | 2 (100) | 8 (72.7) |
2 (100) | 0 (0) | 2 (100) | 5 (71.4) | gyrB | 4(80) | 3 (75) | 2 (100) | 9 (81.8) |
2 (100) | 0 (0) | 0 (0) | 5 (71.4) | grlA | 4(80) | 2 (50) | 1 (50) | 7 (63.6) |
2 (100) | 0 (0) | 2 (100) | 4 (57.1) | grlB | 4(80) | 3 (75) | 1 (50) | 8 (72.7) |